US Stock MarketDetailed Quotes

ALLO Allogene Therapeutics

Watchlist
  • 2.350
  • -0.190-7.48%
Close Jun 14 16:00 ET
  • 2.378
  • +0.028+1.20%
Post 18:52 ET
490.64MMarket Cap-1320P/E (TTM)

Allogene Therapeutics Key Stats

Allogene Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 13, 2024

Revenue(YoY)

22.00K

-26.67%
EPS(YoY)

-0.38

+44.93%

Strong Buy

Jun 4, 2024

Allogene Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 17 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 12.760K--
--2024/Q2-- / 1.777M--
May 13, 20242024/Q122.000K / 10.430K--
Mar 14, 20242023/Q421.000K / 22.400K--
Nov 2, 20232023/Q343.000K / 9.600K--
Aug 2, 20232023/Q244.000K / 18.250K--
May 3, 20232023/Q152.000K / 6.690K--
Feb 28, 20232022/Q447.000K / 64.210K--
Nov 2, 20222022/Q349.000K / 12.570K--
Aug 9, 20222022/Q286.000K / 15.790K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 12.760K--
--2024/Q2-- / 1.777M--
May 13, 20242024/Q122.000K / 10.430K--
Mar 14, 20242023/Q421.000K / 22.400K--
Nov 2, 20232023/Q343.000K / 9.600K--
Aug 2, 20232023/Q244.000K / 18.250K--
May 3, 20232023/Q152.000K / 6.690K--
Feb 28, 20232022/Q447.000K / 64.210K--
Nov 2, 20222022/Q349.000K / 12.570K--
Aug 9, 20222022/Q286.000K / 15.790K--

Unlock Free Earnings Estimates

Allogene Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Jun 4, 2024

Strong Buy

  • Buy

    84.62%
  • Hold

    15.39%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg